Skip to main content
Top
Published in: Diabetes Therapy 1/2018

Open Access 01-02-2018 | Original Research

Hospital Admissions due to Dysglycaemia and Prescriptions of Antidiabetic Medications in England and Wales: An Ecological Study

Authors: Abdallah Y. Naser, Qian Wang, Lisa Y. L. Wong, Jenni Ilomaki, J. Simon Bell, Gang Fang, Ian C. K. Wong, Li Wei

Published in: Diabetes Therapy | Issue 1/2018

Login to get access

Abstract

Introduction

Hypoglycaemia and hyperglycaemia are common adverse events associated with antidiabetic medications. They are also a common cause of hospital admissions for people with diabetes. The objective of the study was to explore the trends in hospital admissions due to hypoglycaemia and hyperglycaemia and in the prescriptions of antidiabetic medications in England and Wales.

Methods

We conducted an observational study during the period 1999–2016. Hospital admission data for patients from all age groups were extracted from the Hospital Episode Statistics database in England and the Patient Episode Database for Wales. Data on prescriptions of antidiabetic medications were extracted from the Prescription Cost Analysis database from 2004 to 2016.

Results

Between 1999 and 2016, the hospital admission rate increased by 173.0% [from 17.2 (95% CI 16.9–17.6) to 47.1 (95% CI 46.5–47.6) per 100,000 persons] for hypoglycaemia and by 147.0% [from 22.8 (95% CI 22.4–23.2) to 56.3 (95% CI 55.7–56.9) per 100,000 persons] for hyperglycaemia. The prescription rate for all antidiabetic medications increased between 2004 and 2016 by 116.0% [from 373.0 (95% CI 373.0–373.0) to 806.0 (95% CI 806.0–806.0) prescriptions per 1000 persons]. There was a parallel increase in the rate of antidiabetic medication prescriptions during the same study period, with correlation coefficients of 0.94 for hypoglycaemia and 0.98 for hyperglycaemia, respectively.

Conclusions

There have been parallel increases in the rate of admissions due to dysglycaemia and the rate of antidiabetic prescriptions in England and Wales. Further analytical studies are required to investigate whether increased admission for dysglycaemia is associated with increased use of antidiabetic medications.
Literature
1.
go back to reference International Diabetes Federation. IDF diabetes atlas. 7th ed. Brussels: International Diabetes Federation; 2015. p. 16–64. International Diabetes Federation. IDF diabetes atlas. 7th ed. Brussels: International Diabetes Federation; 2015. p. 16–64.
2.
go back to reference Hanssen KF. Blood glucose control and microvascular and macrovascular complications in diabetes. Diabetes. 1997;46(2):S101–3.CrossRefPubMed Hanssen KF. Blood glucose control and microvascular and macrovascular complications in diabetes. Diabetes. 1997;46(2):S101–3.CrossRefPubMed
5.
go back to reference Riedel A, et al. Loss of glycemic control in patients with type 2 diabetes mellitus who were receiving initial metformin, sulfonylurea, or thiazolidinedione monotherapy. Pharmacotherapy. 2007;27(8):1102–10.CrossRefPubMed Riedel A, et al. Loss of glycemic control in patients with type 2 diabetes mellitus who were receiving initial metformin, sulfonylurea, or thiazolidinedione monotherapy. Pharmacotherapy. 2007;27(8):1102–10.CrossRefPubMed
6.
go back to reference Umpierrez G, Korytkowski M. Diabetic emergencies—ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia. Nat Rev Endocrinol. 2016;12(4):222–32.CrossRefPubMed Umpierrez G, Korytkowski M. Diabetic emergencies—ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia. Nat Rev Endocrinol. 2016;12(4):222–32.CrossRefPubMed
9.
go back to reference Lipska KJ, et al. National trends in US hospital admissions for hyperglycemia and hypoglycemia among Medicare beneficiaries, 1999 to 2011. JAMA Intern Med. 2014;174(7):1116–24.CrossRefPubMedPubMedCentral Lipska KJ, et al. National trends in US hospital admissions for hyperglycemia and hypoglycemia among Medicare beneficiaries, 1999 to 2011. JAMA Intern Med. 2014;174(7):1116–24.CrossRefPubMedPubMedCentral
10.
go back to reference Zaccardi F, et al. Trends in hospital admissions for hypoglycaemia in England: a retrospective, observational study. Lancet Diabetes Endocrinol. 2016;4(8):677–85.CrossRefPubMed Zaccardi F, et al. Trends in hospital admissions for hypoglycaemia in England: a retrospective, observational study. Lancet Diabetes Endocrinol. 2016;4(8):677–85.CrossRefPubMed
13.
go back to reference Gomez-Huelgas R, et al. The frequency and impact of hypoglycemia among hospitalized patients with diabetes: a population-based study. J Diabetes Complicat. 2015;29(8):1050–5.CrossRefPubMed Gomez-Huelgas R, et al. The frequency and impact of hypoglycemia among hospitalized patients with diabetes: a population-based study. J Diabetes Complicat. 2015;29(8):1050–5.CrossRefPubMed
22.
go back to reference Health and Social Care Information Centre (HSCIC). Prescription Cost Analysis England: 2015 data quality. Leeds: HSCIC; 2016. p. 1–2. Health and Social Care Information Centre (HSCIC). Prescription Cost Analysis England: 2015 data quality. Leeds: HSCIC; 2016. p. 1–2.
26.
27.
go back to reference Clemens KK, et al. Trends in antihyperglycemic medication prescriptions and hypoglycemia in older adults: 2002–2013. PLoS One. 2015;10(9):1–13.CrossRef Clemens KK, et al. Trends in antihyperglycemic medication prescriptions and hypoglycemia in older adults: 2002–2013. PLoS One. 2015;10(9):1–13.CrossRef
28.
go back to reference Zammitt NN, Frier BM. Hypoglycemia in type 2 diabetes: pathophysiology, frequency, and effects of different treatment modalities. Diabetes Care. 2005;28(12):2948–61.CrossRefPubMed Zammitt NN, Frier BM. Hypoglycemia in type 2 diabetes: pathophysiology, frequency, and effects of different treatment modalities. Diabetes Care. 2005;28(12):2948–61.CrossRefPubMed
31.
go back to reference Reid SR, Losek JD. Hypoglycemia complicating dehydration in children with acute gastroenteritis. J Emerg Med. 2005;29(2):141–5.CrossRefPubMed Reid SR, Losek JD. Hypoglycemia complicating dehydration in children with acute gastroenteritis. J Emerg Med. 2005;29(2):141–5.CrossRefPubMed
34.
go back to reference Jin J, et al. Factors affecting therapeutic compliance: a review from the patient’s perspective. Ther Clin Risk Manag. 2008;4(1):269–86.PubMedPubMedCentral Jin J, et al. Factors affecting therapeutic compliance: a review from the patient’s perspective. Ther Clin Risk Manag. 2008;4(1):269–86.PubMedPubMedCentral
35.
go back to reference Walz L, et al. Impact of symptomatic hypoglycemia on medication adherence, patient satisfaction with treatment, and glycemic control in patients with type 2 diabetes. Patient Prefer Adherence. 2014;8:593–601.CrossRefPubMedPubMedCentral Walz L, et al. Impact of symptomatic hypoglycemia on medication adherence, patient satisfaction with treatment, and glycemic control in patients with type 2 diabetes. Patient Prefer Adherence. 2014;8:593–601.CrossRefPubMedPubMedCentral
37.
go back to reference Crawford E. Recommendations for management of diabetes for children in school. Burlington: Vermont Department of Health Diabetes Control Program. p. 1–43. Crawford E. Recommendations for management of diabetes for children in school. Burlington: Vermont Department of Health Diabetes Control Program. p. 1–43.
Metadata
Title
Hospital Admissions due to Dysglycaemia and Prescriptions of Antidiabetic Medications in England and Wales: An Ecological Study
Authors
Abdallah Y. Naser
Qian Wang
Lisa Y. L. Wong
Jenni Ilomaki
J. Simon Bell
Gang Fang
Ian C. K. Wong
Li Wei
Publication date
01-02-2018
Publisher
Springer Healthcare
Published in
Diabetes Therapy / Issue 1/2018
Print ISSN: 1869-6953
Electronic ISSN: 1869-6961
DOI
https://doi.org/10.1007/s13300-017-0349-1

Other articles of this Issue 1/2018

Diabetes Therapy 1/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.